[HTML][HTML] Effectiveness and safety of apixaban vs. warfarin in venous thromboembolism patients with obesity and morbid obesity
This study integrated 5 United States healthcare claims databases to evaluate the risk of
recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE patients …
recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE patients …
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
A Cohen, J Sah, T Lee, L Rosenblatt… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
This study integrated 5 United States healthcare claims databases to evaluate the risk of
recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE patients …
recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE patients …
[HTML][HTML] Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
A Cohen, J Sah, T Lee, L Rosenblatt… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Abstract This study integrated 5 United States healthcare claims databases to evaluate the
risk of recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE …
risk of recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE …
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
A Cohen, J Sah, T Lee, L Rosenblatt… - Journal of Clinical …, 2021 - search.proquest.com
Abstract This study integrated 5 United States healthcare claims databases to evaluate the
risk of recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE …
risk of recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE …
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
A Cohen, J Sah, T Lee, L Rosenblatt… - Journal of Clinical …, 2021 - elibrary.ru
This study integrated 5 United States healthcare claims databases to evaluate the risk of
recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE patients …
recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE patients …
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity.
A Cohen, J Sah, T Lee, L Rosenblatt… - Journal of Clinical …, 2021 - search.ebscohost.com
Abstract This study integrated 5 United States healthcare claims databases to evaluate the
risk of recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE …
risk of recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE …
[PDF][PDF] Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
A Cohen, J Sah, T Lee, L Rosenblatt… - J. Clin …, 2021 - pdfs.semanticscholar.org
This study integrated 5 United States healthcare claims databases to evaluate the risk of
recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE patients …
recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE patients …
Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity.
A Cohen, J Sah, T Lee, L Rosenblatt… - Journal of Clinical …, 2021 - europepmc.org
Abstract This study integrated 5 United States healthcare claims databases to evaluate the
risk of recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE …
risk of recurrent venous thromboembolism (VTE) and major bleeding (MB) among VTE …